← Leaderboards
Christine Didonato
Lurie Children'S Hospital Of Chicago
$4,611,406
Attributed
$4,611,406
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $571.5K · FY2007–18$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$4,611,406 · 4
By mechanism
R01$3,395,736 · 1
R21$1,215,670 · 3
Top collaborators
No co-investigators on record.
Most similar at Lurie Children'S Hospital Of Chicago
Same institution · by research overlap
- Yongchao Charles Ma$3,381,701
Others in their field
Top investigators on “Infant Mortality”
- J Brooks Jackson · Social And Scientific Systems, Inc.$151,807,671
- Sharon A Nachman · Johns Hopkins University$116,441,543
- Rebecca Gersnoviez Clifton · George Washington University$76,467,529
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$65,779,474
- Lawrence Corey · Fred Hutchinson Cancer Center$58,263,037
- Dan H. Barouch · Fred Hutchinson Cancer Center$58,263,037
Research focus
Infant MortalitySpinal Muscular AtrophyGeneticMouse ModelMotor NeuronsSmn2 GeneNucleotidesSurvival Motor Neuron GeneExonsDosageRna SplicingGenesMutationPhenotypePathologyResearch StudyCessation Of LifeSpinal CordCystic FibrosisAmericanBiologyParalysedPathogenesisBypass
Grant awards (20)
Long-term effect of troponin activators for spinal muscular atrophy$189,727
R21 · FY2018 · NS · contact PI
Spinal muscular atrophy: inducing SMN expression$295,953
R01 · FY2017 · NS · contact PI
Long-term effect of troponin activators for spinal muscular atrophy$239,320
R21 · FY2017 · NS · contact PI
Spinal muscular atrophy: inducing SMN expression$345,477
R01 · FY2016 · NS · contact PI
Spinal muscular atrophy: inducing SMN expression$344,977
R01 · FY2015 · NS · contact PI
Spinal Muscular Atrophy: Inducing SMN Expression: Administrative Supplement$31,860
R01 · FY2015 · NS · contact PI
Spinal Muscular Atrophy: Inducing SMN Expression$30,605
R01 · FY2015 · NS · contact PI
Spinal muscular atrophy: inducing SMN expression$390,174
R01 · FY2014 · NS · contact PI
Spinal muscular atrophy: inducing SMN expression$417,830
R01 · FY2013 · NS · contact PI
Development of a novel quinazoline compound for the treatment of spinal muscular$183,750
R21 · FY2011 · NS · contact PI
Spinal Muscular Atrophy: inducing SMN expression$316,626
R01 · FY2010 · NS · contact PI
Development of a novel quinazoline compound for the treatment of spinal muscular$220,500
R21 · FY2010 · NS · contact PI
Spinal Muscular Atrophy: inducing SMN expression$319,824
R01 · FY2009 · NS · contact PI
Spinal Muscular Atrophy: inducing SMN expression$176,682
R01 · FY2009 · NS · contact PI
Spinal Muscular Atrophy: inducing SMN expression$29,011
R01 · FY2009 · NS · contact PI
Spinal Muscular Atrophy: inducing SMN expression$319,824
R01 · FY2008 · NS · contact PI
Creation of hypomorphic panel of Smn mice that mimic human SMN2 splicing$178,128
R21 · FY2008 · HD · contact PI
Spinal Muscular Atrophy: inducing SMN expression$73,500
R01 · FY2008 · NS · contact PI
Spinal Muscular Atrophy: inducing SMN expression$303,393
R01 · FY2007 · NS · contact PI
Creation of hypomorphic panel of Smn mice that mimic human SMN2 splicing$204,245
R21 · FY2007 · HD · contact PI